|
Business Acquisitions - Immunologix, Inc. - Additional Information (Detail) (Immunologix, Inc. [Member], USD $)
In Thousands, except Share data, unless otherwise specified |
1 Months Ended | 12 Months Ended |
|---|---|---|
|
Oct. 21, 2011
|
Dec. 31, 2011
|
|
| Business Acquisition [Line Items] | ||
| Percentage of outstanding common stock acquired | 100.00% | |
| Fair Value of Consideration Transferred | $ 13,850 | |
| Business acquisition, consideration paid, shares issued | 153,365 | |
| Business acquisition, percentage of consideration required | 50.00% | |
| Potential Contingent Consideration Arrangement | 0 | |
| Potential Contingent Consideration Arrangement | 2,000 | |
| Fair value of the contingent consideration arrangement | 0 | |
| Business combination, acquisition related cost | 293 | |
|
Patents and Related Technologies [Member]
|
||
| Business Acquisition [Line Items] | ||
| Acquired Intangible Assets, useful life | 13 years | |
|
Cash [Member]
|
||
| Business Acquisition [Line Items] | ||
| Fair Value of Consideration Transferred | $ 12,758 |
| X | ||||||||||
|
- Definition
Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of shares of equity interests issued or issuable to acquire entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Percentage of voting equity interests acquired at the acquisition date in the business combination. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
For contingent consideration arrangements and indemnification assets recognized in connection with a business combination, this element represents an estimate of the low-end of the potential range (undiscounted) of the consideration which may be paid. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
BusinessAcquisitionContingentConsiderationArrangementPaymentPercentage No definition available.
|